{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:11:49Z","timestamp":1792595509312,"version":"4.5.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Oral cefadroxil has favorable pharmacokinetics for the treatment of bloodstream infection (BSI) and osteomyelitis caused by Gram-positive cocci (GPC), but limited clinical data exist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a multicenter, retrospective cohort study between September 2022 and April 2025 assessing cefadroxil versus intravenous (IV)-only or other oral transitional therapy in adults with susceptible GPC BSI, with or without osteomyelitis. No patients with endocarditis, vertebral osteomyelitis, or prosthetic or central nervous system infections were included. Primary outcome was treatment success, defined as 90-day survival without infection progression or relapse. Prioritized secondary outcomes included all-cause mortality, recurrent bacteremia, and readmission at 90 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 323 patients with BSI, 58 were treated with cefadroxil, 72 IV only, and 193 with other oral antibiotics. Rates of osteomyelitis were comparable in each cohort, but skin and soft-tissue infections were a more common source of bacteremia in cefadroxil (52%) than either IV (28%, P = .01) or orally (PO) (31%, P = .003) cohorts. Staphylococcus aureus was more frequent in the IV (60%) than cefadroxil cohort (36%, P = .008). Nevertheless, cefadroxil-treated patients had a similar case mix index, expected mortality, and expected length of stay as the IV and PO cohorts, indicating comparable populations. Treatment success was similar for cefadroxil (91%), IV (94%, P = .51), and other oral (93%, P = .63) cohorts. Mortality, hospital readmission, and adverse events were comparable between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found similar outcomes for cefadroxil and IV or PO alternatives in patients with GPC BSI, absent endocarditis, vertebral osteomyelitis, prosthetic or central nervous system infection. Cefadroxil was well-tolerated without observed severe adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Point<\/jats:title>\n                    <jats:p>In this multicenter, retrospective cohort study, cefadroxil was an effective and safe oral transitional therapy for bloodstream infections, with or without nonvertebral osteomyelitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag413","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:47:42Z","timestamp":1782920862000},"source":"Crossref","is-referenced-by-count":1,"title":["Cefadroxil as Oral Transitional Therapy for Gram-Positive Bacteremia With or Without Non-Vertebral Osteomyelitis: A Multicenter Retrospective Cohort Study"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4927-4657","authenticated-orcid":false,"given":"Devin C","family":"Clark","sequence":"first","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5620-7286","authenticated-orcid":false,"given":"Rachel","family":"Baden","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3918-0120","authenticated-orcid":false,"given":"Josh","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6568-4063","authenticated-orcid":false,"given":"Rita","family":"Bedrossian","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3815-6081","authenticated-orcid":false,"given":"Hannah","family":"Chute","sequence":"additional","affiliation":[{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5153-2264","authenticated-orcid":false,"given":"Kusha","family":"Davar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0404-8489","authenticated-orcid":false,"given":"Derek","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3434-6877","authenticated-orcid":false,"given":"Matthew","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Southern California Mann School of Pharmacy and Pharmaceutical Sciences , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7118-6100","authenticated-orcid":false,"given":"Reid","family":"Goodman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7856-6173","authenticated-orcid":false,"given":"Hugh","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]},{"name":"Hospital Administration, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglass","family":"Hutcheon","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Jeng","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Olive View-UCLA Medical Center , Sylmar, California ,","place":["USA"]},{"name":"Department of Medicine, University of California at Los Angeles , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Kolluru","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Southern California , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9058-529X","authenticated-orcid":false,"given":"Pamela","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Harbor-UCLA Medical Center , Torrance, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Martinez","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren G","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Harbor-UCLA Medical Center , Torrance, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Minejima","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Southern California Mann School of Pharmacy and Pharmaceutical Sciences , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadym","family":"Mykhaylov","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelyn","family":"Perez","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Russell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Srinivasa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishaque","family":"Syed","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8782-5395","authenticated-orcid":false,"given":"Noah","family":"Wald-Dickler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3632-1709","authenticated-orcid":false,"given":"Brad","family":"Spellberg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]},{"name":"Hospital Administration, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2414-2766","authenticated-orcid":false,"given":"Sarah R","family":"Freling","sequence":"additional","affiliation":[{"name":"Department of Medicine, Los Angeles General Medical Center , Los Angeles, California ,","place":["USA"]},{"name":"Department of Medicine, Keck School of Medicine of USC , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"2026081010284152700_ofag413-B1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/1469-0691.12195","article-title":"Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe","volume":"19","author":"Goto","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"2026081010284152700_ofag413-B2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/1120009X.2018.1516272","article-title":"Distribution of main gram-positive pathogens causing bloodstream infections in United States and European hospitals during the SENTRY antimicrobial surveillance program (2010-2016): concomitant analysis of oritavancin in vitro activity","volume":"30","author":"Mendes","year":"2018","journal-title":"J Chemother"},{"key":"2026081010284152700_ofag413-B3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.26366","article-title":"Guidelines for diagnosis and management of infective endocarditis in adults","volume":"6","author":"McDonald","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026081010284152700_ofag413-B4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.11321","article-title":"Use of novel strategies to develop guidelines for management of pyogenic osteomyelitis in adults","volume":"5","author":"Spellberg","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026081010284152700_ofag413-B5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.amjmed.2025.10.040","article-title":"2025 update to WikiGuidelines for the management of pyogenic osteomyelitis in adults","volume":"139","author":"Spellberg","year":"2025","journal-title":"Am J Med"},{"key":"2026081010284152700_ofag413-B6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N Engl J Med"},{"key":"2026081010284152700_ofag413-B7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N Engl J Med"},{"key":"2026081010284152700_ofag413-B8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/cid\/ciad119","article-title":"Real-world application of oral therapy for infective endocarditis: a multicenter, retrospective, cohort study","volume":"77","author":"Freling","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026081010284152700_ofag413-B9","doi-asserted-by":"crossref","first-page":"ofac706","DOI":"10.1093\/ofid\/ofac706","article-title":"Can the future of ID Escape the inertial dogma of its past? The exemplars of shorter is better and oral is the new IV","volume":"10","author":"Davar","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026081010284152700_ofag413-B10","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.cmi.2023.04.030","article-title":"Choosing patients over placebos: oral transitional therapy vs. IV-only therapy for bacteraemia and infective endocarditis","volume":"29","author":"Phillips","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2026081010284152700_ofag413-B11","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jhm.70041","article-title":"Transition to oral beta-lactam therapy in uncomplicated gram-negative bacteremia: a systematic review and meta-analysis","volume":"20","author":"Dore","year":"2025","journal-title":"J Hosp Med"},{"key":"2026081010284152700_ofag413-B12","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1093\/jac\/dkaf209","article-title":"Efficacy and safety of earlier switching to an oral antibiotic therapy for the treatment of gram-positive bloodstream infections: a systematic review and meta-analysis","volume":"80","author":"Tan","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"2026081010284152700_ofag413-B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/10.suppl_B.1","article-title":"Comparative antibacterial spectrum of cefadroxil","volume":"10","author":"Leitner","year":"1982","journal-title":"J Antimicrob Chemother"},{"key":"2026081010284152700_ofag413-B14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/030006057800600604","article-title":"An overview of results of world-wide clinical trials with cefadroxil","volume":"6","author":"Santella","year":"1978","journal-title":"J Int Med Res"},{"key":"2026081010284152700_ofag413-B15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1099-081X(199605)17:4<319::AID-BDD957>3.0.CO;2-W","article-title":"A pharmacokinetic comparison of cefadroxil and cephalexin after administration of 250, 500 and 1000\u2005mg solution doses","volume":"17","author":"Barbhaiya","year":"1996","journal-title":"Biopharm Drug Dispos"},{"key":"2026081010284152700_ofag413-B16","doi-asserted-by":"crossref","first-page":"ofad610","DOI":"10.1093\/ofid\/ofad610","article-title":"First-generation cephalosporins for treatment of acute hematogenous osteomyelitis in children: a study of efficacy and adverse effects","volume":"10","author":"Hiskey","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026081010284152700_ofag413-B17"},{"key":"2026081010284152700_ofag413-B18","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2146\/ajhp150841","article-title":"Why isn't cefadroxil used more often?","volume":"73","author":"Corson","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"2026081010284152700_ofag413-B19","doi-asserted-by":"crossref","first-page":"ofae280","DOI":"10.1093\/ofid\/ofae280","article-title":"Variation in North American Infectious Disease Specialists' practice regarding oral and suppressive antibiotics for adult osteoarticular infections: results of an emerging Infections Network (EIN) survey","volume":"11","author":"Cortes-Penfield","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026081010284152700_ofag413-B20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.idc.2025.02.009","article-title":"Optimizing antibiotic therapy in musculoskeletal infections","volume":"39","author":"Cortes-Penfield","year":"2025","journal-title":"Infect Dis Clin North Am"},{"key":"2026081010284152700_ofag413-B21","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"2026081010284152700_ofag413-B22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116207","article-title":"Compliance with once-daily versus twice or thrice-daily administration of antibiotic regimens: a meta-analysis of randomized controlled trials","volume":"10","author":"Falagas","year":"2015","journal-title":"PLoS One"},{"key":"2026081010284152700_ofag413-B23","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/AAC.02626-15","article-title":"Relationship between adherence to oral antibiotics and postdischarge clinical outcomes among patients hospitalized with Staphylococcus aureus skin infections","volume":"60","author":"Eells","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2026081010284152700_ofag413-B24","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/jpids\/piac104","article-title":"Cefadroxil use for musculoskeletal infections in an academic pediatric hospital","volume":"11","author":"Weslander","year":"2022","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"S1","key":"2026081010284152700_ofag413-B25","doi-asserted-by":"crossref","first-page":"s34","DOI":"10.1017\/ash.2024.143","article-title":"Cefadroxil is an option for gram-positive bone and joint infections in adults","volume":"4","author":"Kluthe","year":"2024","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2026081010284152700_ofag413-B26","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1093\/cid\/ciaf707","article-title":"Using the comparing oral versus parenteral antimicrobial therapy (COPAT) clinical trial to influence institutional practice transformation towards earlier transition to oral antibiotics","volume":"82","author":"Juskowich","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026081010284152700_ofag413-B27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/1120009X.2022.2031469","article-title":"Oral step-down therapy in patients with uncomplicated Staphylococcus aureus primary bacteremia and catheter-related bloodstream infections","volume":"34","author":"Mun","year":"2022","journal-title":"J Chemother"},{"key":"2026081010284152700_ofag413-B28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"2026081010284152700_ofag413-B29"},{"key":"2026081010284152700_ofag413-B30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.amjmed.2021.10.007","article-title":"Oral is the new IV. Challenging decades of blood and bone infection dogma: a systematic review","volume":"135","author":"Wald-Dickler","year":"2022","journal-title":"Am J Med"},{"key":"2026081010284152700_ofag413-B31"},{"key":"2026081010284152700_ofag413-B32","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2026081010284152700_ofag413-B33","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/cid\/ciz112","article-title":"Changing characteristics of Staphylococcus aureus bacteremia: results from a 21-year, prospective, longitudinal study","volume":"69","author":"Souli","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026081010284152700_ofag413-B34","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cid\/ciad666","article-title":"Early oral antibiotic switch in Staphylococcus aureus bacteraemia: the Staphylococcus aureus network adaptive platform (SNAP) trial early oral switch protocol","volume":"79","author":"de Kretser","year":"2024","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/8\/ofag413\/70507455\/ofag413.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/8\/ofag413\/70507455\/ofag413.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:28:55Z","timestamp":1786372135000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag413\/8753193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag413","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8,1]]},"article-number":"ofag413"}}